Results 211 to 220 of about 58,284 (283)

Routine Molecular Surveillance of Drug-Resistant Tuberculosis: Translating Mutation Proxies into Clinical Governance Intelligence in Rural Eastern Cape. [PDF]

Healthcare (Basel)
Sonka B, Hosu MC, Dlatu N, Makola TV, Faye LM.   +4 more
europepmc   +1 more source

Breakthrough Tuberculosis in a Large Cohort of People Living With HIV on Preventive Treatment. [PDF]

Trop Med Int Health
Ruswa N, Günther G, Claassens M.
europepmc   +1 more source

Differential regulation of monocyte oxidative burst by isoniazid in healthy and latent tuberculosis-infected subjects. [PDF]

Front Pharmacol
Gal J, Sönnerbrandt M, Braian C, Schön T, Blomgran R.   +4 more
europepmc   +1 more source

Cost-effectiveness of latent tuberculosis infection testing and preventive treatment among TB contacts in China: a Markov model. [PDF]

BMC Health Serv Res
Li J, Wen Y, Ge F, Qiu Y, Xu C.
europepmc   +1 more source

Discovery of novel InhA inhibitors through structural bioinformatics and machine learning-driven QSAR screening of natural products. [PDF]

Biol Methods Protoc
Anthony GI, Nwosu SN, Owolade AJ, Kehinde TO, Teye RG, Akor SE, Fabuyi FS, Nwafor IR, Oleh PK, Ilori TD, Bodun DS.   +10 more
europepmc   +1 more source

First-line drug-resistant tuberculosis among children under 15 years in Ethiopia: insights from phenotypic and whole-genome sequencing approaches. [PDF]

BMC Infect Dis
Abebaw Y, Ayele A, Ghodousi A, Alemayehu DH, Gebremicael G, Diriba G, Seid G, Cabibbe AM, Abebe M, Sheth A, Argaw R, Abegaz WE.   +11 more
europepmc   +1 more source

Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial. [PDF]

PLoS Med
Durovni B, Cordeiro-Santos M, Cavalcante SC, Spener-Gomes R, Garcia J, Cohn S, Saraceni V, Kohler B, Moulton LH, Brito da Souza A, Berihun A, Marzinke M, Chaisson RE, Ultra Curto Study Team.   +13 more
europepmc   +1 more source

Case report: CNS tuberculoma in a patient with prior pulmonary tuberculosis. [PDF]

QJM
Mehta S, Prabhu MM, Nayak M V, Suvarna R.   +3 more
europepmc   +1 more source

Pattern and prevalence of rifampicin and isoniazid-resistant tuberculosis using genotype MTBDR<i>plus</i> assay in Ethiopia. [PDF]

Microbiol Spectr
Getahun M, Ameni G, Mollalign H, Diriba G, Beyene D.   +4 more
europepmc   +1 more source

Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs. [PDF]

Infect Drug Resist
He K, Zhang J, Du X, He X, Zeng Y, Liu M.   +5 more
europepmc   +1 more source